# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-006755
Filing Date
2025-01-17
Accepted
2025-01-17 16:34:50
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sclx-20240930.htm iXBRL | 10-Q | 3583176
2 | EX-31.1 | sclx-ex31_1.htm | EX-31.1 | 13438
3 | EX-31.2 | sclx-ex31_2.htm | EX-31.2 | 12761
4 | EX-32.1 | sclx-ex32_1.htm | EX-32.1 | 12593
| Complete submission text file | 0000950170-25-006755.txt |  | 13847841

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sclx-20240930.xsd | EX-101.SCH | 2207431
78 | EXTRACTED XBRL INSTANCE DOCUMENT | sclx-20240930_htm.xml | XML | 2052300

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39852 | Film No.: 25539151
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)